CME

Faculty: Brendon Neuen, MBBS, PhD Faculty: Katherine Tuttle, MD A growing body of evidence presented at ERA 2026 is reshaping the conversation around chronic kidney disease management, regardless of diabetes status. In this expert interview, Dr. Katherine Tuttle and Dr. Brendon Neuen examine emerging data on nonsteroidal mineralocorticoid receptor antagonists and discuss how recent findings may...

Faculty: Lina Badimón, MD, PhD Faculty: Michelle O’Donoghue, MD, MPH Faculty: Erin Michos, MD, MHS Faculty: Pam R. Taub, MD A new modular CME-accredited program designed to support clinicians in translating evolving lipid guidelines into everyday practice. Delivered as a 60-minute webcast, divided into chapters for convenience, it integrates U.S. and international perspectives and focuses on...

Faculty: Muthiah Vaduganathan, MD, MPH Faculty: Koichiro Kinugawa, MD Faculty: Michael Böhm, MD In this panel discussion from the ESC Heart Failure Congress 2026, Drs. Muthu Vaduganathan, Michael Böhm, and Koichiro Kinugawa discuss the role of nonsteroidal MRAs in patients with HFmrEF and HFpEF. Using a clinical case, the faculty review evolving recommendations supporting finerenone as part of...

Chair: Iacopo Olivotto Faculty: Elena Arbelo Faculty: Silvia Aguiar Did you miss our symposium at ESC HF 2026? It’s not too late! This CME-accredited broadcast replay focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM). Learn how to distinguish oHCM from heart failure and how cardiac myosin inhibitors can optimize patient outcomes. Join us and gain...

Faculty: J.A. Randy Englert, MD, FACC Faculty: Matthew Malachowski, Pharm. D., MHA This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing...

Faculty: J.A. Randy Englert, MD, FACC Faculty: Matthew Malachowski, Pharm. D., MHA This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing...

Faculty: J.A. Randy Englert, MD, FACC Faculty: Matthew Malachowski, Pharm. D., MHA This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing...

Faculty: J.A. Randy Englert, MD, FACC Faculty: Matthew Malachowski, Pharm. D., MHA This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing...

Faculty: J.A. Randy Englert, MD, FACC This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing LDL-C–centered treatment strategies, and...

Faculty: J.A. Randy Englert, MD, FACC Faculty: Matthew Malachowski, Pharm. D., MHA This MinuteCE program brings a practical, team-based approach to improving atherosclerotic cardiovascular disease (ASCVD) prevention. Featuring expert multidisciplinary insights from Joseph Englert, MD, and Matt Malachowski, PharmD, this series focuses on identifying high-risk and underserved patients, advancing...